[Refractory macrophage activation syndrome in children with systemic onset juvenile idiopathic arthritis treated with canakinumab].

Authors	X N Zhu, T Y He, S L Luo, Y Y Huang, Y B Xu, S L Liu, J Yang
Journal	Zhonghua er ke za zhi = Chinese journal of pediatrics (Zhonghua Er Ke Za Zhi) Vol. 61 Issue 9 Pg. 842-844 (Sep 02 2023) ISSN: 0578-1310 [Print] China
PMID	37650168 (Publication Type: Journal Article)
Chemical References	canakinumab Antibodies, Monoclonal, Humanized
Topics	Child Humans Arthritis, Juvenile (complications, drug therapy) Macrophage Activation Syndrome (drug therapy, etiology) Antibodies, Monoclonal, Humanized (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!